HIGH PHRENIC, LOW CAPTURE THRESHOLD PACING DEVICES AND METHODS

• US 20080077186A1
• Filed: 04/12/2007
• Published: 03/27/2008
• Est. Priority Date: 04/18/2006
• Status: Abandoned Application

• Current Assignee: Proteus Digital Health, Inc. (Otsuka Holdings Company Limited)
• Original Assignee: Proteus Biomedical, Inc. (Otsuka Holdings Company Limited)
• Inventors: Savage, George, Costello, Benedict, Zdeblick, Mark, Thompson, Todd, Colliou, Olivier, Jensen, Marc
• Application Number:
  US11/734,617
• Publication Number:
  US 20080077186A1
• Time in Patent Office: Days
• US Class Current: 607/9
• CPC Class Codes: A61N 1/3627 for treating a mechanical deficiency of the heart, e.g. congestive heart failure or cardiomyopathy

Abstract

Methods of highly selective cardiac tissue stimulation and devices for practicing the same, e.g., implantable segmented electrode devices, are provided. The methods and devices provide a previously unavailable high phrenic nerve capture voltage paired with a low pacing capture voltage threshold. The subject methods and devices provide a number of benefits. For example, patients who previously would have been required to have their resynchronization device turned off due to phrenic nerve capture will now be able to reap the benefits of resynchronization therapy.

Claims

1. A method comprising:

implanting an implantable medical device have an electrical tissue stimulation element into a subject; and

activating said electrical tissue stimulation element in a manner sufficient to stimulation tissue with high selectivity.

2. The method according to claim 1, wherein said tissue is cardiac tissue.

3. The method according to claim 2, wherein said method is a method of stimulating cardiac tissue in a manner that has a high phrenic nerve capture threshold.

4. The method according to claim 3, wherein said method has a low cardiac tissue capture threshold.

5. The method according to claim 2, wherein said method includes obtaining phrenic nerve capture data.

6. The method according to claim 5, wherein said obtaining of said phrenic nerve capture data comprises employing a sensor.

7. The method according to claim 5, wherein said obtaining of said phrenic nerve capture data comprises employing non-cardiac pacing pulses.

8. The method according to claim 5, wherein said method further comprises employing said obtained phrenic nerve capture data in determining a cardiac pacing protocol.

9. The method according to claim 2, wherein said method comprises employing a segmented electrode structure that includes two or more distinct electrode elements.

10. The method according to claim 9, wherein said method comprises activating at least one of said electrodes of said structure to deliver electrical energy to said subject.

11. The method according to claim 10, wherein at least a first of said electrodes is connected to a first conductive member and a second of said electrodes is connected to a second conductive member.

12. The method according to claim 10, wherein said method comprises not activating at least one of said electrodes.

13. The method according to claim 10, wherein said method further comprises determining which of said electrodes to activate.

14. The method according to claim 10, wherein said method comprises activating said electrodes in manner sufficient to not stimulate the phrenic nerve.

15. A system comprising:

at least one implantable lead comprising a segmented electrode; and

a control unit configured to operate said lead according to a method of claim 1.

16. A kit comprising:

at least one implantable lead comprising a segmented electrode; and

a control unit configured to operate said lead according to a method of claim 1.